For these reasons, androgen deprivation therapy (ADT) is an effective treatment in prostate cancer, although most patients progress to castration-resistant prostate cancer with an increase of AR expression levels and hypersensitivity to androgen-based therapies. This evidence concerns the gene AR and prostate cancer.